Would you like to contribute to this site?
Arthritis Menu
Submit an Article
Submit a Tip
Place your Ad
Add URL
Arthritis Questions?
Contact Us
Related Topics:
Rheumatoid Arthritis
Rheumatoid Arthritis Causes
Rheumatoid Arthritis Complication
Rheumatoid Arthritis Cure
Rheumatoid Arthritis Diagnosis
Rheumatoid Arthritis Disability
Rheumatoid Arthritis Drugs
Rheumatoid Arthritis Eyes
Rheumatoid Arthritis Knee
Rheumatoid Arthritis Medications
Rheumatoid Arthritis Nodules
Rheumatoid Arthritis Nutrition
Rheumatoid Arthritis Pregnancy
Rheumatoid Arthritis Prevention
Rheumatoid Arthritis Support
Rheumatoid Arthritis Test
Rheumatoid Arthritis Treatments
Other Channels:
|
 |
|
|
|
|
|
|
|
|
Recent Questions and Answers
|
|
|
|
|
|
|
|
Recent Rheumatoid Arthritis Causes News:
|
|
|

BRUSSELS , Dec. 21, 2011 /PRNewswire/ -- UCB today announced the start of the EXXELERATE™ study which will evaluate the short- and long-term efficacy of Cimzia® (certolizumab pegol) plus methotrexate (MTX) ...
Rheumatoid arthritis affects 1.3 million Americans, and is two to three times more common among women. It is a chronic disease that affects the joints, primarily those in the hands, wrists, feet, shoulders and knees.
(Reuters) - U.S. health regulators have accepted the application for Pfizer Inc's closely watched experimental rheumatoid arthritis drug, the drugmaker said on Tuesday. The Food and Drug Administration is due to decide on the drug, tofacitinib, in August. Pfizer said it has also submitted an application for tofacitinib to regulatory authorities in Japan. Tofacitinib is one of Pfizer's most ...
The treatment has proved successful in animal studies conducted by the Weizmann Institute in Rehovot, Israel, and it is hoped the breakthrough could lead to new ways of tackling a range of conditions.
UCB today announced the start of the EXXELERATE study which will evaluate the short- and long-term efficacy of Cimzia (certolizumab pegol) plus methotrexate (MTX) compared with that of Humira(adalimumab) plus MTX in the treatment of moderate to severe rheumatoid arthritis (RA). The start of this study confirms previously announced plans.
|
|
| |
|
|
|
Additional Rheumatoid Arthritis Causes Resources:
|
|
|
|
|
|
|
|
|
Want your site featured on this page?
|
|
 |
|